Primary FDA-Approved Indications
Used in adolescents for episodic cold sores, chronic suppression, and treatment of VZV when indicated.
Recurrent HSV labialis
FDA ApprovedAdolescentsRandomized trials
Evidence Sources
()
HSV suppression
FDA ApprovedChildren and adolescentsClinical trials
Evidence Sources
()
Varicella or zoster treatment
FDA ApprovedChildren โฅ2 yearsCDC guidance
Evidence Sources
()